SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001999371-24-010145
Filing Date
2024-08-14
Accepted
2024-08-14 16:05:20
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G eliem-sc13ga_081424.htm SC 13G/A 75673
  Complete submission text file 0001999371-24-010145.txt   77347
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Subject) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92797 | Film No.: 241207471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

IRS No.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A